Bronchiectasis

Bronchiectasis (bron-kee-ech-tuh-sis) is a common but frequently undiagnosed condition caused by chronic inflammation of the airways.1 Bronchiectasis (BE) widens and scars the airways of the lungs so they can’t effectively help clear out mucus as they normally would. This can result in chronic inflammation and infections. If untreated, BE can result in a cycle of worsening symptoms.2
Bronchiectasis illustration

BE symptoms and complications

 
  • Declining lung function3
  • Chronic productive cough4
  • Chronic mucus secretion4
  • Repeated chest infections that require antibiotics3,6
  • Need for supplemental oxygen3,6
  • One or more hospital stays per year3,6

Bronchiectasis and chronic obstructive pulmonary disease

Although BE was once thought to be a rare condition, emerging evidence shows that it is far more common than originally believed. It’s now understood to be closely associated with COPD. 7
%50 logo

It's estimated that half of people living with serious COPD many have BE.3

 

Although there is no cure for BE, early diagnosis followed by vest therapy can lead to a better quality of life while slowing or preventing future lung damage.If you or someone you care for are experiencing BE symptoms, see your doctor. A high resolution CT scan can confirm a case of BE. Getting a medical diagnosis from your physician can be the first step to breathing – and living – more comfortably.

Breathe easier—the Philips InCourage system can help

The goal is to reduce the risk of bacterial infection by clearing out mucus before it builds up. After one year of InCourage vest therapy, patients in RespirTech’s bronchiectasis patient outcomes program* reported**:
hospital icon

Yearly rate of hospitalization dropped

arrow down

62%

lungs icon

Ability to clear lungs

Good-excellent rating increased
arrow up

62%

health rate icon

Respiratory health

Good-excellent rating increased
arrow up

43%

antibiotic icon

Antibiotic use decreased

arrow down

14%

Talk to your doctor – could you have bronchiectasis?

 

To determine if you may be a candidate for vest therapy, please answer the following questions. You can share this information with your healthcare provider.

Do you currently have moderate-to-severe COPD, chronic bronchitis or bronchiectasis?

Yes

No

In the last 12 months, have you been hospitalized two or more times for respiratory issues?

Yes

No

In the last 12 months, have you needed antibiotics to treat cough/infection more than three times?

Yes

No

Have you been coughing up mucus for longer than three months?

Yes

No

Does your cough impact your daily activities?

Yes

No

If you answered “yes” to any of the questions, talk with your doctor.

 

Many of the symptoms can be associated with bronchiectasis (BE), a chronic respiratory condition that can produce excess mucus in the lungs that is difficult to cough out. If you have not yet been screened for bronchiectasis, your doctor may order a high resolution CT scan to check for the condition.

Fill out our inquiry form to receive a BE information packet filled with educational materials to bring to your doctor.

 

Our specialists are always happy to answer any questions you or your physician may have.

800.793.1261

8 a.m. to 5 p.m. CT

Monday - Friday

**No matching rule found. Please select another answer
Anyone with COPD or bronchiectasis knows how debilitating it can be – it completely wipes you out. Antibiotics were a way of life for me. Once I received my [Philips] InCourage therapy vest, within the first week I noticed that clearing my lungs was extremely easy. No antibiotics***, no lung infections since starting using the vest.”

-Autum E., PA, COPD and bronchiectasis

We’re here to help you on your journey to better breathing.

 

Fill out the form below to receive your RespirTech BE information kit, then talk with your doctor to see if the InCourage system may be right for you.

References

1. Maselli DJ, Amalakuhan B, Keyt H, Diaz AA. Suspecting non-cystic fibrosis bronchiectasis: What the busy primary care clinician needs to know. Int J Clin Pract. 2017;71(2):e12924.
2. Cole P. The damaging role of bacteria in chronic lung infection. J Antimicrob Chemother 1997;40 Suppl A:5-10.
3. Martínez-García MA, de la Rosa Carrillo D, Soler-Cataluña JJ, et al. Prognostic value of bronchiectasis in patients with moderate-to-severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2013;187:823–831.
4. King P. Pathogenesis of bronchiectasis. Pediatr Respir Rev. 2011;e011;12 (2):104-110.  
5.Weycker D E, J, Oster G, Tino G. Prevalence and Economic Burden of Bronchiectasis. Clin Pulm Med. 2005;12(4):205-209.
6. Du Q, Jin J, Liu X, Sun Y. Bronchiectasis as a Comorbidity of Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis. PloS one. 2016;11(3):e0150532.    
7. Blasi F, Chalmers JD, Aliberti S. COPD and bronchiectasis: phenotype, endotype or co-morbidity? COPD. 2014;11(6):603- 604.
8. Martínez-García MA, de la Rosa Carrillo D, Soler-Cataluña JJ, et al. Prognostic value of bronchiectasis in patients with moderate-to-severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2013;187:823–831.
9. American Thoracic Society. ATS Patient Education Series. Am J Respir Crit Care Med 2017:195;15-16.

*Methodology: As of  6/30/19, self-reported data from over 16,000 bronchiectasis patients.​
**RespirTech's bronchiectasis patient outcomes program consists of follow-up calls at periodic intervals for up to two years to encourage HFCWO adherence and ensure the device is properly set for individual needs.
*** Individual results may vary
Respitech
5905 Nathan Lane North, Suite 200, Plymouth, MN 55442
©2019 Koninklijke Philips N.V. All rights reserved.